Roberto Francesco Bellini - Feb 14, 2025 Form 4 Insider Report for Inhibikase Therapeutics, Inc. (IKT)

Role
Director
Signature
/s/ Roberto Bellini
Stock symbol
IKT
Transactions as of
Feb 14, 2025
Transactions value $
$0
Form type
4
Date filed
2/19/2025, 08:18 PM
Previous filing
Oct 23, 2024
Next filing
Jul 2, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IKT Stock Option (Right to Buy) Award $0 +73.6K $0.00 73.6K Feb 14, 2025 Common Stock 73.6K $2.35 Direct F1
transaction IKT Stock Option (Right to Buy) Award $0 +117K $0.00 117K Feb 14, 2025 Common Stock 117K $2.35 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vested and became exercisable on February 14, 2025.
F2 The options will vest and become exercisable in two equal annual installments on October 24, 2025 and October 24, 2026.